i10 Productivity
Rankings
Eli Lilly and Company/ Scientists i10 Productivity Rankings 2025
Productivity Rankings is a unique service offered only by “AD Scientific Index”. This is a ranking system derived from the i10 index in order to show the productivity of the scientist in publishing scientific articles of value. Productivity Rankings is an instrument that lists productive scientists in a given area, discipline, university, and country and can guide the development of meaningful incentives and academic policies. The world rankings, regional rankings, and university rankings of scientists in this table are developed based on the total i10 index. Additionally, click to view the special rankings based on Productivity Rankings: Scientists Last 6 years' i10 Index", Universities Total i10 Index Rankings 2025, Universities Last 6 Years i10 Index Rankings 2025 "Art and Humanities i10 Productivity Rankings" and "Social Sciences and Humanities i10 Productivity Rankings".
* Total i10 IndexRankings
Ranking Based On Selection :1
psychosis
neurodegeneration
bioinformatics
genomics
drug development
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
442
255
0.577
* Total i10 IndexRankings
Ranking Based On Selection :2
Immuno-Oncology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
212
111
0.524
* Total i10 IndexRankings
Ranking Based On Selection :3
Drug Discovery
Informatics
Computational Chemistry
Biophysics
Nanotechnology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
207
190
0.918
* Total i10 IndexRankings
Ranking Based On Selection :4
PBPK Models
DDI
CYPs
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
175
106
0.606
* Total i10 IndexRankings
Ranking Based On Selection :5
GI cancer
translational research
lung cancer
phase 1 trials
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
175
85
0.486
* Total i10 IndexRankings
Ranking Based On Selection :6
process chemistry
organic chemistry. pharmaceutical
green chemistry
catalysis
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
145
74
0.510
* Total i10 IndexRankings
Ranking Based On Selection :7
Neuroscience & Drug Discovery
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
142
88
0.620
* Total i10 IndexRankings
Ranking Based On Selection :8
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
140
33
0.236
* Total i10 IndexRankings
Ranking Based On Selection :9
Neurodegeneration
Neuroscience
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
135
77
0.570
* Total i10 IndexRankings
Ranking Based On Selection :10
oncology/I-O/autoimmune diseases
drug discovery
kinases
epigenetics
RNA modulation
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
112
41
0.366
* Total i10 IndexRankings
Ranking Based On Selection :11
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
105
88
0.838
* Total i10 IndexRankings
Ranking Based On Selection :12
Clinical research
patients
methodology
effectiveness
cost-effectiveness
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
103
41
0.398
* Total i10 IndexRankings
Ranking Based On Selection :13
Osteoporosis
Migraine
Cardiovascular Disease
Drug Development
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
98
74
0.755
* Total i10 IndexRankings
Ranking Based On Selection :14
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
88
51
0.580
* Total i10 IndexRankings
Ranking Based On Selection :15
diabetes
cardiovascular diseases
osteoporosis
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
86
52
0.605
* Total i10 IndexRankings
Ranking Based On Selection :16
Alzheimer's disease
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
83
80
0.964
* Total i10 IndexRankings
Ranking Based On Selection :17
Alzheimer's disease
Neurodegeneration
Drug discovery
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
82
62
0.756
* Total i10 IndexRankings
Ranking Based On Selection :18
Drug Discovery
G-proteins
GPCRs
Receptors
Pharmacology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
81
53
0.654
* Total i10 IndexRankings
Ranking Based On Selection :19
Lipoprotein Metabolism and Atherosclerosis
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
75
46
0.613
* Total i10 IndexRankings
Ranking Based On Selection :20
Diabetes
endocrinology
fatty liver disease
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
75
40
0.533
* Total i10 IndexRankings
Ranking Based On Selection :21
Heart disease
inflammation
diabetes
noncoding RNAs
systems biology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
73
57
0.781
* Total i10 IndexRankings
Ranking Based On Selection :22
psychopharmamcology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
72
42
0.583
* Total i10 IndexRankings
Ranking Based On Selection :23
Computational chemistry
molecular modeling
biophysics
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
72
22
0.306
* Total i10 IndexRankings
Ranking Based On Selection :24
Health outcomes
pediatrics
epidemiology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
68
42
0.618
* Total i10 IndexRankings
Ranking Based On Selection :25
Statistics
Applied statistics in drug discovery
Translational research
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
67
37
0.552
David A Collier
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
442
255
0.577
psychosis
neurodegeneration
bioinformatics
genomics
drug development
Prachi Sharma
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
212
111
0.524
Jiye Shi
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
207
190
0.918
Drug Discovery
Informatics
Computational Chemistry
Biophysics
Nanotechnology
Stephen Hall
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
175
106
0.606
David R Ferry
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
175
85
0.486
Tony Zhang
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
145
74
0.510
process chemistry
organic chemistry. pharmaceutical
green chemistry
catalysis
Christian C Felder
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
142
88
0.620
Neuroscience & Drug Discovery
Jonathan A Lee
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
140
33
0.236
Michael O'Neill
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
135
77
0.570
Bob Campbell
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
112
41
0.366
oncology/I-O/autoimmune diseases
drug discovery
kinases
epigenetics
RNA modulation
Eswar Krishnan
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
105
88
0.838
José Antonio Sacristán
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
103
41
0.398
Clinical research
patients
methodology
effectiveness
cost-effectiveness
JH Krege
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
98
74
0.755
David H Adams
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
88
51
0.580
Imre Pavo
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
86
52
0.605
Stéphane Epelbaum
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
83
80
0.964
Martin Citron
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
82
62
0.756
Francis Willard
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
81
53
0.654
Drug Discovery
G-proteins
GPCRs
Receptors
Pharmacology
Giacomo Ruotolo
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
75
46
0.613
Mark L Hartman
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
75
40
0.533
Diabetes
endocrinology
fatty liver disease
Scot J Matkovich
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
73
57
0.781
Heart disease
inflammation
diabetes
noncoding RNAs
systems biology
Joel Raskin
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
72
42
0.583
Howard Broughton
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
72
22
0.306
Computational chemistry
molecular modeling
biophysics
Joe Johnston
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
68
42
0.618
Health outcomes
pediatrics
epidemiology
Richard E Higgs
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
67
37
0.552
Statistics
Applied statistics in drug discovery
Translational research